Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data

Clin Rheumatol. 2020 Oct;39(10):3161. doi: 10.1007/s10067-020-05356-1.

Authors

Chak Sing Lau¹, Yi-Hsing Chen², Keith Lim³, Marc de Longueville⁴, Catherine Arendt⁴, Kevin Winthrop⁵

Affiliations

¹ Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pok Fu Lam, Hong Kong. cslau@hku.hk.
² Taichung Veterans General Hospital, Taichung, Taiwan.
³ Western Health Rheumatology Unit and AIMSS, Melbourne University, Melbourne, Australia.
⁴ UCB Pharma, Brussels, Belgium.
⁵ Oregon Health and Science University, Portland, OR, USA.

Abstract

The original published version of the above article contained an error.

Publication types

Published Erratum